Healthcare investor Triventures backs genomics company Genoox in $6 million funding round
May 15, 2018 / Bill Siwicki
Genoox, a genomic analytics company that aims to make it easier for clinicians and researchers to act on genetic sequencing results, today announced it has secured $6 million in a funding round. The round was led by Triventures, a venture capital fund that invests in healthcare startups, and was joined by Inimiti Capital and Glilot Capital Partners. As the appetite for direct-to-consumer genetic testing services grows, the $5 billion global market is witnessing an increase in demand for testing services that empower physicians to use genetic data for diagnostics and preventative medicine.